Latest Wright Medical Group (WMGI) Headlines
Wright Medical Group Reaches Agreement with ODE - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:20PM CDT
Last year, FDA issued a "not-approvable letter" in response to the PMA application submitted by Wright Medical Group for Augment Bone Graft.
Wright Medical Group, Inc. Announces Agreement with FDA Office of Device Evaluation to File PMA Amendment for Augment(R) Bone Graft In Lieu of Dispute Resolution Panel
Business Wire - Mon Mar 10, 4:23PM CDT
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced it has reached an agreement with the Office of Device Evaluation (ODE) of the U.S. Food and Drug Administration (FDA) under which ODE will accept a further amendment to the Pre-Market Approval application (PMA) for Augment(R) Bone Graft in lieu of proceeding with the Dispute Resolution Panel (DRP) that was scheduled for the week of May 19, 2014. The agreement with ODE remains subject to final approval by the FDA appeal authority. That approval is expected shortly.
Post Earnings Update: Wright Medical Has Sunk 6.0% Lower in Past 2 Weeks (WMGI)
Comtex SmarTrend(R) - Mon Mar 10, 7:38AM CDT
When Wright Medical (NASDAQ:WMGI) reported earnings two weeks ago on February 24th, 2014, analysts, on average, expected the company to report a loss of $0.18 on sales of $65.0 million. The company actually reported a loss of $0.17 per share on sales of $67.8 million, beating EPS estimates by $0.01 and beating revenue estimates by $2.8 million. Shares of Wright Medical have slipped from $33.80 to $31.77, representing a loss of 6.0%, since the company reported earnings 14 days ago.
Nordion Signs Two-Year Strontium-82 Supply Contract with Bracco Diagnostics
Business Wire - Tue Mar 04, 7:01AM CST
Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it has entered into a two-year contract with Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, to supply strontium-82, a cyclotron based medical isotope produced both at Nordion's Vancouver, British Columbia and Ottawa, Ontario facilities.
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
Wright Medical Group Sees Wider Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 9:00AM CST
For full-year 2013, Wright Medical Group posted a wider adjusted loss of $25.2 million or 48 cents per share compared with $3.8 million or 10 cents per share in 2012.
Wright Medical Group, Inc. Reports 2013 Fourth Quarter and Full-Year Financial Results and Provides 2014 Guidance
Business Wire - Mon Feb 24, 3:00PM CST
--Fourth Quarter Global Foot and Ankle Net Sales Increase 22% As Reported and 22% Constant Currency
Majority of Patients with Serious Type of Bowel Disease Suffering Unnecessarily from Debilitating Symptoms
Business Wire - Fri Feb 21, 10:56AM CST
Patients with a serious type of inflammatory bowel disease, ulcerative colitis, are not satisfied with their current treatments and the majority do not have their disease under control, according to new research released today at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen. The majority (87.2 per cent) of the 250 patients with moderate to severe ulcerative colitis who were being treated with standard therapies failed to achieve control of their disease - defined either as going into remission or not having needed to use corticosteroid medications in the previous two months.(1)
Wright Medical Group, Inc. to Participate in Barclays Global Healthcare Conference
Business Wire - Tue Feb 18, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Barclays Global Healthcare Conference on Tuesday, March 11, 2014, at the Loews Miami Beach Hotel in Miami Beach, Florida. Robert Palmisano, president and chief executive officer, will present at 9:30 a.m. Eastern Time.
Wright Medical Group, Inc. Completes Acquisition of OrthoPro, LLC
Business Wire - Wed Feb 05, 3:00PM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it has completed its acquisition of OrthoPro, LLC (OrthoPro), a high-growth extremities company. Along with the acquisition of Solana Surgical announced last week, this transaction adds complementary extremity product portfolios to further accelerate growth opportunities in Wright's global Extremities business.
Wright Medical Group, Inc. to Participate in 2014 RBC Capital Markets' Healthcare Conference
Business Wire - Wed Feb 05, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ:WMGI) announced today that it will be participating in the RBC Capital Markets' Healthcare Conference on Wednesday, February 26, 2014, at the New York Palace Hotel in New York, New York. Lance Berry, chief financial officer, will present at 8:00 a.m. Eastern Time.
Wright Medical Group, Inc. to Host Fourth Quarter 2013 Earnings Conference Call
Business Wire - Mon Feb 03, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Monday, February 24, 2014, at 3:30 p.m. Central Time to discuss the Company's operating results for its fourth quarter ended December 31, 2013. Operating results will be released at 3:00 p.m. Central Time that day.
Wright Medical Group, Inc. Announces Acquisition of Solana Surgical, LLC and Entry into Definitive Agreement to Acquire OrthoPro, LLC
Business Wire - Thu Jan 30, 3:46PM CST
--Purchase Price of $90 Million in Cash and Stock for Solana Surgical and Up to $36 Million in Cash for OrthoPro
Wright Medical Has Returned 16.5% Since SmarTrend Recommendation (WMGI)
Comtex SmarTrend(R) - Thu Jan 30, 11:12AM CST
SmarTrend identified an Uptrend for Wright Medical (NASDAQ:WMGI) on September 11th, 2013 at $26.19. In approximately 5 months, Wright Medical has returned 16.48% as of today's recent price of $30.50.
Wright Medical Up 18.0% Since SmarTrend Uptrend Call (WMGI)
Comtex SmarTrend(R) - Thu Jan 23, 9:50AM CST
SmarTrend identified an Uptrend for Wright Medical (NASDAQ:WMGI) on September 11th, 2013 at $26.19. In approximately 4 months, Wright Medical has returned 18.02% as of today's recent price of $30.91.
Wright Medical Rises on OrthoRecon Sale - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 17, 1:50PM CST
Wright Medical's decision to sell off its OrthoRecon unit bodes well for the company.
Shares of WMGI Up 23.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 16, 9:10AM CST
SmarTrend identified an Uptrend for Wright Medical (NASDAQ:WMGI) on September 11th, 2013 at $26.19. In approximately 4 months, Wright Medical has returned 23.10% as of today's recent price of $32.24.
MicroPort Scientific establishes MicroPort Orthopedics through acquisition of Wright Medical's OrthoRecon business
PR Newswire - Mon Jan 13, 9:53AM CST
MicroPort Scientific Corporation (HK: 0853), announced on January 9, 2014 the closing of the transaction to acquire the OrthoRecon business from Wright Medical Group, Inc. (NASDAQ: WMGI). The transaction establishes MicroPort Orthopedics as the sixth largest multinational hip and knee reconstruction company, with global headquarters in Arlington, Tennessee. As a result of the acquisition, MicroPort now holds U.S. manufacturing, global infrastructure, logistics and operations in the top four global orthopedic markets, as well as established hip and knee franchise brands.
Wright Medical Group, Inc. Completes Divestiture of OrthoRecon Business
Business Wire - Thu Jan 09, 4:01PM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced the closing of the transaction to divest its OrthoRecon business to MicroPort Scientific Corporation (HK: 0853) and its affiliates. The closing of the transaction occurred on January 9, 2014.
Medtronic to Acquire TYRX - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 08, 5:00PM CST
Medtronic makes investment in TYRX
Wright Medical Group Reaches Agreement with ODE - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:20PM CDT
Last year, FDA issued a "not-approvable letter" in response to the PMA application submitted by Wright Medical Group for Augment Bone Graft.
Wright Medical Group, Inc. Announces Agreement with FDA Office of Device Evaluation to File PMA Amendment for Augment(R) Bone Graft In Lieu of Dispute Resolution Panel
Business Wire - Mon Mar 10, 4:23PM CDT
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced it has reached an agreement with the Office of Device Evaluation (ODE) of the U.S. Food and Drug Administration (FDA) under which ODE will accept a further amendment to the Pre-Market Approval application (PMA) for Augment(R) Bone Graft in lieu of proceeding with the Dispute Resolution Panel (DRP) that was scheduled for the week of May 19, 2014. The agreement with ODE remains subject to final approval by the FDA appeal authority. That approval is expected shortly.
Post Earnings Update: Wright Medical Has Sunk 6.0% Lower in Past 2 Weeks (WMGI)
Comtex SmarTrend(R) - Mon Mar 10, 7:38AM CDT
When Wright Medical (NASDAQ:WMGI) reported earnings two weeks ago on February 24th, 2014, analysts, on average, expected the company to report a loss of $0.18 on sales of $65.0 million. The company actually reported a loss of $0.17 per share on sales of $67.8 million, beating EPS estimates by $0.01 and beating revenue estimates by $2.8 million. Shares of Wright Medical have slipped from $33.80 to $31.77, representing a loss of 6.0%, since the company reported earnings 14 days ago.
Nordion Signs Two-Year Strontium-82 Supply Contract with Bracco Diagnostics
Business Wire - Tue Mar 04, 7:01AM CST
Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it has entered into a two-year contract with Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, to supply strontium-82, a cyclotron based medical isotope produced both at Nordion's Vancouver, British Columbia and Ottawa, Ontario facilities.
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
Wright Medical Group Sees Wider Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 9:00AM CST
For full-year 2013, Wright Medical Group posted a wider adjusted loss of $25.2 million or 48 cents per share compared with $3.8 million or 10 cents per share in 2012.
Wright Medical Group, Inc. Reports 2013 Fourth Quarter and Full-Year Financial Results and Provides 2014 Guidance
Business Wire - Mon Feb 24, 3:00PM CST
--Fourth Quarter Global Foot and Ankle Net Sales Increase 22% As Reported and 22% Constant Currency
Majority of Patients with Serious Type of Bowel Disease Suffering Unnecessarily from Debilitating Symptoms
Business Wire - Fri Feb 21, 10:56AM CST
Patients with a serious type of inflammatory bowel disease, ulcerative colitis, are not satisfied with their current treatments and the majority do not have their disease under control, according to new research released today at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen. The majority (87.2 per cent) of the 250 patients with moderate to severe ulcerative colitis who were being treated with standard therapies failed to achieve control of their disease - defined either as going into remission or not having needed to use corticosteroid medications in the previous two months.(1)
Wright Medical Group, Inc. to Participate in Barclays Global Healthcare Conference
Business Wire - Tue Feb 18, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) announced today that it will be participating in the Barclays Global Healthcare Conference on Tuesday, March 11, 2014, at the Loews Miami Beach Hotel in Miami Beach, Florida. Robert Palmisano, president and chief executive officer, will present at 9:30 a.m. Eastern Time.
Wright Medical Group, Inc. Completes Acquisition of OrthoPro, LLC
Business Wire - Wed Feb 05, 3:00PM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it has completed its acquisition of OrthoPro, LLC (OrthoPro), a high-growth extremities company. Along with the acquisition of Solana Surgical announced last week, this transaction adds complementary extremity product portfolios to further accelerate growth opportunities in Wright's global Extremities business.
Wright Medical Group, Inc. to Participate in 2014 RBC Capital Markets' Healthcare Conference
Business Wire - Wed Feb 05, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ:WMGI) announced today that it will be participating in the RBC Capital Markets' Healthcare Conference on Wednesday, February 26, 2014, at the New York Palace Hotel in New York, New York. Lance Berry, chief financial officer, will present at 8:00 a.m. Eastern Time.
Wright Medical Group, Inc. to Host Fourth Quarter 2013 Earnings Conference Call
Business Wire - Mon Feb 03, 5:00AM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Monday, February 24, 2014, at 3:30 p.m. Central Time to discuss the Company's operating results for its fourth quarter ended December 31, 2013. Operating results will be released at 3:00 p.m. Central Time that day.
Wright Medical Group, Inc. Announces Acquisition of Solana Surgical, LLC and Entry into Definitive Agreement to Acquire OrthoPro, LLC
Business Wire - Thu Jan 30, 3:46PM CST
--Purchase Price of $90 Million in Cash and Stock for Solana Surgical and Up to $36 Million in Cash for OrthoPro
Wright Medical Has Returned 16.5% Since SmarTrend Recommendation (WMGI)
Comtex SmarTrend(R) - Thu Jan 30, 11:12AM CST
SmarTrend identified an Uptrend for Wright Medical (NASDAQ:WMGI) on September 11th, 2013 at $26.19. In approximately 5 months, Wright Medical has returned 16.48% as of today's recent price of $30.50.
Wright Medical Up 18.0% Since SmarTrend Uptrend Call (WMGI)
Comtex SmarTrend(R) - Thu Jan 23, 9:50AM CST
SmarTrend identified an Uptrend for Wright Medical (NASDAQ:WMGI) on September 11th, 2013 at $26.19. In approximately 4 months, Wright Medical has returned 18.02% as of today's recent price of $30.91.
Wright Medical Rises on OrthoRecon Sale - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 17, 1:50PM CST
Wright Medical's decision to sell off its OrthoRecon unit bodes well for the company.
Shares of WMGI Up 23.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 16, 9:10AM CST
SmarTrend identified an Uptrend for Wright Medical (NASDAQ:WMGI) on September 11th, 2013 at $26.19. In approximately 4 months, Wright Medical has returned 23.10% as of today's recent price of $32.24.
MicroPort Scientific establishes MicroPort Orthopedics through acquisition of Wright Medical's OrthoRecon business
PR Newswire - Mon Jan 13, 9:53AM CST
MicroPort Scientific Corporation (HK: 0853), announced on January 9, 2014 the closing of the transaction to acquire the OrthoRecon business from Wright Medical Group, Inc. (NASDAQ: WMGI). The transaction establishes MicroPort Orthopedics as the sixth largest multinational hip and knee reconstruction company, with global headquarters in Arlington, Tennessee. As a result of the acquisition, MicroPort now holds U.S. manufacturing, global infrastructure, logistics and operations in the top four global orthopedic markets, as well as established hip and knee franchise brands.
Wright Medical Group, Inc. Completes Divestiture of OrthoRecon Business
Business Wire - Thu Jan 09, 4:01PM CST
Wright Medical Group, Inc. (NASDAQ: WMGI) today announced the closing of the transaction to divest its OrthoRecon business to MicroPort Scientific Corporation (HK: 0853) and its affiliates. The closing of the transaction occurred on January 9, 2014.
Medtronic to Acquire TYRX - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 08, 5:00PM CST
Medtronic makes investment in TYRX
